{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:24:06Z","timestamp":1778160246530,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.amjms.2023.07.006","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T12:30:56Z","timestamp":1689856256000},"page":"245-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pulmonary fibrosis and COVID-19"],"prefix":"10.1016","volume":"366","author":[{"given":"Daniel","family":"Kramer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2023.07.006_bib0001","unstructured":"WHO Coronavirus (COVID-19) Dashboard. WHO Coronavirus (COVID-19) Dashboard. Accessed Feb 28, 2023. https:\/\/covid19.who.int\/."},{"key":"10.1016\/j.amjms.2023.07.006_bib0002","article-title":"Covid-19: risk factors for severe disease and death","volume":"368","author":"Jordan","year":"2020","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.amjms.2023.07.006_bib0003","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/jmv.25889","article-title":"The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis","volume":"92","author":"Zhao","year":"2020","journal-title":"J Med Virol"},{"issue":"10354","key":"10.1016\/j.amjms.2023.07.006_bib0004","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet"},{"issue":"150","key":"10.1016\/j.amjms.2023.07.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"Suppl 2","key":"10.1016\/j.amjms.2023.07.006_bib0006","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1513\/AnnalsATS.201502-088AW","article-title":"Viruses in idiopathic pulmonary fibrosis. etiology and exacerbation","volume":"12","author":"Moore","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"150","key":"10.1016\/j.amjms.2023.07.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0071-2018","article-title":"Acute exacerbations of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Kolb","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"12","key":"10.1016\/j.amjms.2023.07.006_bib0008","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1164\/rccm.202006-2441LE","article-title":"Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control study","volume":"202","author":"Esposito","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.amjms.2023.07.006_bib0009","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1164\/rccm.202007-2638LE","article-title":"Risk Factors for mortality after COVID-19 in patients with preexisting interstitial lung disease","volume":"203","author":"Gallay","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.amjms.2023.07.006_bib0010","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1164\/rccm.202007-2794OC","article-title":"Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter Study","volume":"202","author":"Drake","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.amjms.2023.07.006_bib0011","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04125-2020","article-title":"Interstitial lung disease increases susceptibility to and severity of COVID-19","volume":"58","author":"Lee","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjms.2023.07.006_bib0012","article-title":"Reduction in COPD exacerbations during COVID-19: a systematic review and meta-analysis","author":"Alqahtani","year":"2021","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000758","article-title":"Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort","volume":"8","author":"de Boer","year":"2021","journal-title":"BMJ Open Respir Res"},{"issue":"7","key":"10.1016\/j.amjms.2023.07.006_bib0014","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1164\/rccm.202102-0389ED","article-title":"Asthma in the time of COVID-19","volume":"203","author":"Martinez","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.amjms.2023.07.006_bib0015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.resinv.2021.06.007","article-title":"COVID-19 and acute exacerbation of interstitial lung disease","volume":"59","author":"Kondoh","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.amjms.2023.07.006_bib0016","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12890-021-01463-0","article-title":"Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis","volume":"21","author":"So","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2021203153","article-title":"Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia","volume":"299","author":"Han","year":"2021","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.amjms.2023.07.006_bib0018","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4103\/ijri.IJRI_469_16","article-title":"Follow-up chest radiographic findings in patients with MERS-CoV after recovery","volume":"27","author":"Das","year":"2017","journal-title":"Indian J Radiol Imaging"},{"key":"10.1016\/j.amjms.2023.07.006_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.103590","article-title":"Post COVID-19 pulmonary fibrosis; a meta-analysis study","author":"Hama Amin","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.amjms.2023.07.006_bib0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41413-020-0084-5","article-title":"Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study","volume":"8","author":"Zhang","year":"2020","journal-title":"Bone Res"},{"key":"10.1016\/j.amjms.2023.07.006_bib0021","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1440-1843.2009.01624.x","article-title":"Determinants of initiation and progression of idiopathic pulmonary fibrosis","volume":"14","author":"Kottmann","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.amjms.2023.07.006_bib0022","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.med.55.091902.103810","article-title":"Mechanisms of pulmonary fibrosis","volume":"55","author":"Thannickal","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.amjms.2023.07.006_bib0023","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","article-title":"Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix","volume":"103","author":"Kim","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.amjms.2023.07.006_bib0024","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1513\/pats.201112-055AW","article-title":"The genetic and environmental causes of pulmonary fibrosis","volume":"9","author":"Macneal","year":"2012","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.amjms.2023.07.006_bib0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ccm.2016.11.013","article-title":"Viral pneumonia and acute respiratory distress syndrome","volume":"38","author":"Shah","year":"2017","journal-title":"Clin Chest Med"},{"issue":"5","key":"10.1016\/j.amjms.2023.07.006_bib0026","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.amjms.2023.07.006_bib0027","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s13665-018-0210-7","article-title":"Risk factors for the development of idiopathic pulmonary fibrosis: A review","volume":"7","author":"Zaman","year":"2018","journal-title":"Curr Pulmonol Rep"},{"key":"10.1016\/j.amjms.2023.07.006_bib0028","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.chest.2019.10.032","article-title":"Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis","volume":"157","author":"Sheng","year":"2019","journal-title":"Chest"},{"issue":"38","key":"10.1016\/j.amjms.2023.07.006_bib0029","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.3748\/wjg.14.5880","article-title":"Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis","volume":"14","author":"Arase","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.amjms.2023.07.006_bib0030","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/rmed.2001.1151","article-title":"Infection of TT virus in patients with idiopathic pulmonary fibrosis","volume":"95","author":"Bando","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.amjms.2023.07.006_bib0031","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1164\/rccm.201103-0516OC","article-title":"PDGF-producing CD4+ FoxP3+ regulatory T lymphocytes promote lung fibrosis","volume":"184","author":"Lo Re","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.amjms.2023.07.006_bib0032","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/cells11060986","article-title":"EGFR Signaling in Lung Fibrosis","volume":"11","author":"Schramm","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.amjms.2023.07.006_bib0033","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1164\/rccm.200905-0659OC","article-title":"Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis","volume":"182","author":"Kim","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjms.2023.07.006_bib0034","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2023.07.006_bib0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1164\/rccm.200804-550OC","article-title":"Telomere shortening in familial and sporadic pulmonary fibrosis","volume":"178","author":"Cronkhite","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.006_bib0036","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1128\/CMR.00014-10","article-title":"The airway epithelium: soldier in the fight against respiratory viruses","volume":"24","author":"Vareille","year":"2011","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.amjms.2023.07.006_bib0037","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.amjms.2021.12.010","article-title":"Endothelial dysfunction in Covid-19 infection","volume":"363","author":"Otifi","year":"2022","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.006_bib0038","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41420-021-00437-9","article-title":"Role of interleukins in the pathogenesis of pulmonary fibrosis","volume":"7","author":"She","year":"2021","journal-title":"Cell Death Discov"},{"issue":"5","key":"10.1016\/j.amjms.2023.07.006_bib0039","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1378\/chest.108.5.1303","article-title":"Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome","volume":"108","author":"Meduri","year":"1995","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.006_bib0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2249.1997.d01-905.x","article-title":"Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters","volume":"107","author":"Takizawa","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"16","key":"10.1016\/j.amjms.2023.07.006_bib0041","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMe2103108","article-title":"Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup","volume":"384","author":"Rubin","year":"2021","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.amjms.2023.07.006_bib0042","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.amjms.2023.07.006_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.amjms.2023.07.006_bib0044","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/his.14249","article-title":"Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China","volume":"78","author":"Li","year":"2021","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.amjms.2023.07.006_bib0045","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1164\/rccm.201211-1981OC","article-title":"Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy","volume":"187","author":"Thille","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjms.2023.07.006_bib0046","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13613-021-00904-7","article-title":"High risk of patient self-inflicted lung injury in COVID-19 with frequently encountered spontaneous breathing patterns: a computational modelling study","volume":"11","author":"Weaver","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"2","key":"10.1016\/j.amjms.2023.07.006_bib0047","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/CCM.0000000000001379","article-title":"Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: role of tidal volume","volume":"44","author":"Carteaux","year":"2016","journal-title":"Critical Care Medicine"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.006_bib0048","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40635-017-0142-5","article-title":"Hyperoxia provokes a time- and dose-dependent inflammatory response in mechanically ventilated mice, irrespective of tidal volumes","volume":"5","author":"Helmerhorst","year":"2017","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.amjms.2023.07.006_bib0049","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/cc13778","article-title":"Protective mechanical ventilation in the non-injured lung review and meta-analysis","volume":"18","author":"Sutherasan","year":"2014","journal-title":"Crit Care"},{"issue":"27","key":"10.1016\/j.amjms.2023.07.006_bib0050","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjms.2023.07.006_bib0051","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02806-2021","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination","volume":"59","author":"Bando","year":"2022","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.amjms.2023.07.006_bib0052","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/j.chest.2022.08.2213","article-title":"Acute Exacerbation of interstitial lung disease After SARS-CoV-2 vaccination: a case series","volume":"162","author":"Ishioka","year":"2022","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.amjms.2023.07.006_bib0053","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.chest.2021.07.2160","article-title":"An acute exacerbation of idiopathic pulmonary fibrosis after BNT162b2 mRNA COVID-19 vaccination: a case report","volume":"161","author":"Ghincea","year":"2022","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.amjms.2023.07.006_bib0054","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2169\/internalmedicine.49.3890","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis after pandemic influenza A (H1N1) vaccination","volume":"49","author":"Umeda","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.amjms.2023.07.006_bib0055","doi-asserted-by":"crossref","unstructured":"Tahtinen S, Tong A-J, Himmels P, et al. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat Immunol. 23(4):532-542.","DOI":"10.1038\/s41590-022-01160-y"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.006_bib0056","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jiac.2021.09.010","article-title":"COVID-19 vaccine induced interstitial lung disease","volume":"28","author":"Yoshifuji","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.amjms.2023.07.006_bib0057","unstructured":"VigiAccess. Accessed December 22, 2022. https:\/\/www.vigiaccess.org"},{"issue":"8","key":"10.1016\/j.amjms.2023.07.006_bib0058","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.amjms.2023.07.006_bib0059","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid-19","volume":"383","author":"Berlin","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2023.07.006_bib0060","article-title":"Lung recovery with prolonged ECMO following fibrotic COVID-19 acute respiratory distress syndrome","author":"Kazi","year":"2022","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjms.2023.07.006_bib0061","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.amjms.2023.07.006_bib0062","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09059180.00001111","article-title":"Antifibrotic activities of pirfenidone in animal models","volume":"20","author":"Schaefer","year":"2011","journal-title":"Eur Respir Rev"},{"issue":"2","key":"10.1016\/j.amjms.2023.07.006_bib0063","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/14782715221103402","article-title":"Nintedanib vs pirfenidone in the management of COVID-19 lung fibrosis: A single-centre study","volume":"52","author":"Singh","year":"2022","journal-title":"J R College Phys Edinburgh"},{"key":"10.1016\/j.amjms.2023.07.006_bib0064","unstructured":"The Study of the use of Nintedanib in slowing lung disease in patients with fibrotic or non-fibrotic interstitial lung disease related to COVID-19 - full text view - ClinicalTrials.gov. (https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04619680). Accessed on 18 May 2023."},{"key":"10.1016\/j.amjms.2023.07.006_bib0065","unstructured":"Pirfenidone vs. Nintedanib for fibrotic lung disease after coronavirus disease-19 pneumonia - full text view - ClinicalTrials.gov [Internet]. [cited 2023 May 18]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04856111"},{"key":"10.1016\/j.amjms.2023.07.006_bib0066","unstructured":"Nintedanib for the treatment of SARS-Cov-2 induced pulmonary fibrosis - full text view - ClinicalTrials.gov [Internet]. [cited 2023 May 18]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04541680"},{"key":"10.1016\/j.amjms.2023.07.006_bib0067","unstructured":"US Food and Drug Administration. FDA Guidance on conduct of clinical trials of medical products during COVID-19 Public Health Emergency: Guidance for industry, investigators, and institutional review boards. Docket number: FDA-2020-D-1106-0002. Last updated August 2021). Available at:https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency. Accessed March 3, 2023."},{"key":"10.1016\/j.amjms.2023.07.006_bib0068","unstructured":"US Department of Health & Human Services. Secretary Azar declares public health emergency for United States for 2019 novel coronavirus. Available at: https:\/\/www.hhs.gov\/news. Accessed March 3, 2023."},{"key":"10.1016\/j.amjms.2023.07.006_bib0069","article-title":"Covid-19 two years on: persistent symptoms of clinical trial disruption trouble certain therapy areas","author":"Hillman","year":"2022","journal-title":"Clin Trials Arena"},{"key":"10.1016\/j.amjms.2023.07.006_bib0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.amjms.2020.06.011","article-title":"Conducting clinical research in the era of COVID-19","volume":"360","author":"Perez","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjms.2023.07.006_bib0071","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.710573","article-title":"Effect of Surgical Masks on Cardiopulmonary Function in Healthy Young Subjects: A Crossover Study","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.006_bib0072","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.amjms.2020.08.017","article-title":"Acute exacerbation of interstitial lung disease as a sequela of COVID-19 pneumonia","volume":"361","author":"Fonseca","year":"2021","journal-title":"Am J Med Sci"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923012600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923012600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:43:40Z","timestamp":1757702620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962923012600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0002962923012600"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2023.07.006","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary fibrosis and COVID-19","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2023.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}